Tras

Lantern Pharma Advances Unique ADC (Antibody Drug Conjugate) Program Across Multiple Solid Tumor Cancers

Retrieved on: 
Thursday, February 15, 2024
Biotechnology, Technology, Other Health, Health, Pharmaceutical, Oncology, Research, Software, Artificial Intelligence, Science, Clinical Trials, Neoplasm, DAR, Multimedia, Drug resistance, Political moderate, Cancer, Drug development, Spacecraft, Drug discovery, ADC, HER2, Breast, Trastuzumab, MMAE, Bielefeld University, Tras, Immortalised cell line, Fine chemical

Lantern Pharma Inc. (NASDAQ: LTRN), a leader in AI-driven cancer drug discovery and development, announced an important milestone in its antibody-drug conjugate (ADC) program.

Key Points: 
  • Lantern Pharma Inc. (NASDAQ: LTRN), a leader in AI-driven cancer drug discovery and development, announced an important milestone in its antibody-drug conjugate (ADC) program.
  • In collaboration with Bielefeld University, Lantern has generated a new class of highly specific and highly potent ADCs with a cryptophycin drug-payload.
  • View the full release here: https://www.businesswire.com/news/home/20240215526567/en/
    Preclinical results from Lantern's cryptophycin ADC (Cp-ADC) in HER2 expressing cancers in comparison with commercially available MMAE payload antibody-drug conjugates (ADCs).
  • These efforts aim to improve ADC development for specific patient populations and potentially guide more effective future clinical treatments with less cost and greater efficiency than historical ADC drug development.

Merck Highlights Innovative Oncology Portfolio and Pipeline at ESMO Congress 2023 Underscoring Commitment to Advancing Cancer Research and Improving Patient Outcomes Across Multiple Stages of Disease

Retrieved on: 
Tuesday, October 10, 2023
Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, MSD, NYSE, Abstract, Breast cancer, Brentuximab vedotin, INT, Trastuzumab, RCC, Survival, Endometrial cancer, PEM, NRG, ESMO, Merck & Co., Webcast, Belzutifan, European Society for Medical Oncology, ADC, Research, TUC, KRAS, Lung cancer, RAS, AstraZeneca, EC, Adenocarcinoma, Head, TNBC, MRK, Pembrolizumab, Everolimus, CRC, Cancer, Olaparib, EFS, Quality of life (healthcare), SWOG, Congress, LBA32, LBA21, PBO, Chemoradiotherapy, CP, Safety, MBC, Patient, Pharmaceutical industry, Birth control, Medical imaging, Animal feed, Vaccine, Tras, Merck, NSCLC, Eisai

The event will take place virtually and will be accessible via webcast.

Key Points: 
  • The event will take place virtually and will be accessible via webcast.
  • Safety and preliminary efficacy of the KRAS G12C inhibitor MK-1084 in solid tumors and in combination with pembrolizumab in NSCLC.
  • Pathologic response and exploratory analyses of neoadjuvant-adjuvant versus adjuvant pembrolizumab (PEM) for resectable stage IIIB-IV melanoma from SWOG S1801.
  • mRNA-4157 (V940) individualized neoantigen therapy + pembrolizumab vs pembrolizumab in high-risk resected melanoma: Clinical efficacy and correlates of response.

Parallaxes Capital Highlights Terminated TRA of a Leading Food and Beverage Company

Retrieved on: 
Tuesday, December 6, 2022
IPO, Parallax, Inc., TRA, Pepsi, Ecosystem, PepsiCo, Tras, Acquisition, Security (finance)

NEW YORK, Dec. 6, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").

Key Points: 
  • NEW YORK, Dec. 6, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as PepsiCo Inc. ("Pepsi") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes was founded in 2017 and is comprised of experienced investment professionals from leading private equity and growth equity firms.

Parallaxes Capital Highlights Terminated TRA of a Leading Provider of Digital Infrastructure Solutions

Retrieved on: 
Wednesday, November 30, 2022
Research, Ecosystem, TRA, Tras, Vertiv, IPO, Parallax, Inc., Security (finance)

In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Vertiv Holdings Co. ("Vertiv") previously terminated its TRA.

Key Points: 
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Vertiv Holdings Co. ("Vertiv") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.
  • Parallaxes was founded in 2017 and is comprised of experienced investment professionals from leading private equity and growth equity firms.

Blog: International transfers: empowering innovation and growth whilst protecting people’s personal information

Retrieved on: 
Thursday, November 24, 2022
Transfer, TRA, Addendum, Blog, SCCS, Table, Risk, European Data Protection Board, Privacy, Private law, Tras, Regulation, Commercial, IDTA, Risk management

A blog by Emma Bate

Key Points: 
  • A blog by Emma Bate
    17 November 2022
    Its important that businesses and organisations know how to protect peoples personal information when making international transfers, which are central to the increasingly global nature of businesses.
  • Our work in this area aims to provide certainty, for all involved, that the right level of protection is in place.
  • This blog and associated products is aimed at all businesses and organisations which transfer data internationally, and civil society.
  • What we have published
    Earlier this year we published the International Data Transfer Agreement (IDTA) and the Addendum to the European Union Standard Contractual Clauses (SCCs).

Parallaxes Capital Management Highlights Previously Terminated TRA of a Leading Provider of Packaging, Print and Facility Solutions

Retrieved on: 
Thursday, November 17, 2022
Ecosystem, NOLS, IPO, Veritiv, Tras, TRA, Parallax, Inc., Security (finance)

In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Veritiv Corporation ("Veritiv") previously terminated its TRA.

Key Points: 
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Veritiv Corporation ("Veritiv") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.
  • Parallaxes was founded in 2017 and is comprised of experienced investment professionals from leading private equity and growth equity firms.

Parallaxes Capital Management Highlights Previously Terminated TRA of a Leading Internet Company

Retrieved on: 
Tuesday, November 8, 2022
Ecosystem, Solution, Tras, Awareness, GoDaddy, Depreciation, TRA, IPO, Security (finance), Parallax, Inc.

NEW YORK, Nov. 8, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes"), is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").

Key Points: 
  • NEW YORK, Nov. 8, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes"), is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes, is pleased to highlight a notable development in the market as GoDaddy Inc. ("GoDaddy") previously terminated its TRAs.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.

Parallaxes Capital Management Highlights Previously Terminated TRA of a Leading Insurance Technology Company

Retrieved on: 
Thursday, November 3, 2022
IPO, Acquisition, Awareness, Madison Dearborn Partners, MDP, Tras, Ecosystem, Parallax, Inc., Solution, TRA, Security (finance)

NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").

Key Points: 
  • NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Benefytt Technologies, Inc. ("Benefytt") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.

Parallaxes Capital Management Highlights Previously Terminated TRA of a Leading Agriculture Technology Company

Retrieved on: 
Wednesday, November 2, 2022
Awareness, Dow Chemical Company, Solution, TRA, Acquisition, Ecosystem, Parallax, Inc., IPO, Tras, Security (finance)

NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").

Key Points: 
  • NEW YORK, Nov. 1, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as AgroFresh Solutions Inc. ("AgroFresh") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.

Parallaxes Capital Management Highlights Previously Terminated TRA of a Leading Oil and Gas Company

Retrieved on: 
Thursday, October 27, 2022
TRA, Solution, Awareness, IPO, Tras, Parallax, Inc., Acquisition, Ecosystem, Pioneer Natural Resources, Security (finance), Parsley

NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").

Key Points: 
  • NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Parallaxes Capital Management ("Parallaxes") is an alternative asset manager and, since 2017, has raised four funds dedicated to Tax Receivable Agreements ("TRAs").
  • In the vein of creating greater visibility into the TRA ecosystem, Parallaxes is pleased to highlight a notable development in the market as Parsley Energy, Inc. ("Parsley") previously terminated its TRA.
  • Parallaxes Capital Management ("Parallaxes") is the premier investment firm focused exclusively on monetizing Tax Receivable Agreements ("TRAs").
  • Parallaxes offers private equity sponsors, co-investors and management team members solutions to achieve liquidity, diversification and optionality from their TRAs.